n-isopropylacrylamide has been researched along with Disease Models, Animal in 2 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, W; Liu, X; Qin, M; Wu, S; Xu, M; Zhang, D; Zhang, Y | 1 |
| Chen, WY; Du, S; Guan, YQ; Li, CH; Niu, S; Yin, L; You, R; Zhan, X; Zhang, L; Zhang, LK; Zhuang, S | 1 |
2 other study(ies) available for n-isopropylacrylamide and Disease Models, Animal
| Article | Year |
|---|---|
Role and mechanism of lncRNA under magnetic nanoparticles in atrial autonomic nerve remodeling during radiofrequency ablation of recurrent atrial fibrillation.
Topics: Acrylamides; Animals; Atrial Fibrillation; Autonomic Pathways; Catheter Ablation; Disease Models, Animal; Dogs; Heart Atria; High-Throughput Nucleotide Sequencing; Magnetite Nanoparticles; RNA, Long Noncoding; Sequence Analysis, RNA; Transcriptome | 2022 |
Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model.
Topics: Acrylamides; alpha-Synuclein; Animals; Biological Products; Disease Models, Animal; Drug Carriers; Endocytosis; Genetic Therapy; Magnetite Nanoparticles; Male; Mice, Inbred C57BL; Nerve Growth Factor; Neurons; Parkinson Disease; Plasmids; RNA, Small Interfering | 2017 |